| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Departments of Obstetrics and Gynecology [D. A. F., Y. L., M. S. S.] and Cell and Molecular Biology [S. M. E., M. S. S.] and the R. H. Lurie Comprehensive Cancer Center [D. A. F., M. S. S.], Northwestern University Medical School, Chicago, Illinois 60611
 |
ABSTRACT |
|---|
 Top ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Ovarian cancer cells secrete proteolytic enzymes including plasminogen activators and MMPs that degrade extracellular matrix proteins and promote invasion into the proteolytically modified tissue (reviewed in Ref. 11 ). Expression of gelatinolytic and collagenolytic MMPs including MMP-2 (gelatinase A), MMP-9 (gelatinase B), and MT1-MMP has been demonstrated in ovarian cancer ascites, cultured cells, and tissues (11, 12, 13) . Furthermore, treatment of animals harboring ovarian cancer xenografts with synthetic MMP inhibitors reduces tumor burden and enhances survival (14 , 15) . Numerous studies have shown that MT1-MMP functions in the activation of proMMP-2 (16, 17, 18) , and it has been speculated that MT1-MMP produced by ovarian epithelial carcinoma cells may initiate cell surface activation of tumor-derived or stromally derived proMMP-2, thereby facilitating motility, invasion, and metastasis (12 , 19 , 20) . We have previously demonstrated that clustering of collagen-binding integrins on ovarian cancer cell membranes induces proMMP-2 activation (12) . Furthermore, activated MMP-2 binds to the plasma membranes of ovarian cancer cells where it displays significantly enhanced catalytic efficiency relative to the solution phase enzyme (21) and promotes a 3–5-fold increase in cellular invasive activity (19) . Because MT1-MMP also catalyzes direct proteolysis of extracellular matrix macromolecules, including collagens (22 , 23) , induction of a MT1-MMP/MMP-2 cascade is postulated to play a significant role in ovarian cancer i.p. invasion.
Previous studies have demonstrated that LPA induces secretion of urinary-type plasminogen activator (urokinase) by ovarian cancer cells (24) ; however, the effect of LPA on MMP production has not been evaluated. In the current study, we investigated the effect of LPA on MMP activity generated by ovarian cancer cells. Our results demonstrate that LPA stimulates proMMP-2 activation and promotes ovarian tumor cell motility and invasion in an MMP-dependent manner. Together, these data suggest that LPA-induced increases in pericellular MMP activity may function to potentiate ovarian cancer invasion and metastasis.
|
MATERIALS AND METHODS |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Cell Culture and LPA Treatment.
The ovarian carcinoma cell line DOV 13 was provided by Dr. Robert Bast, Jr. (M. D. Anderson Cancer Center, Houston, TX). Cell culture was maintained under standard conditions in 75-cm2 cell culture flasks (26)
. LPA was dissolved in chloroform, evaporated, and resuspended in cold PBS containing 1% BSA (24)
. Cells were subcultured at a density of 105 cells/well in 24-well plates under serum-free conditions in the presence of LPA (0–200 µM) for 12–48 h. The effect of LPA on cell growth was evaluated by culturing cells for 24–72 h in the presence of LPA (0–200 µM) and monitoring cellular metabolic activity using the CellTiter 96AQ kit according to the manufacturer’s specifications. There was no difference in metabolic activity in cells cultured with up to 200 µM LPA for 72 h (P > 0.05). In control experiments, cultures included PTX (100 ng/ml), which blocks LPA signaling through its G protein-coupled receptor (27
, 28)
. Additional control cultures included Con A (20 µg/ml) to induce proMMP-2 activation and MT1-MMP processing or MMPI (10 µM) to inhibit MMP processing (12)
. Conditioned media and cell lysates were collected and evaluated for MMP expression and activity as described below.
Cell Adhesion and Integrin Expression.
To evaluate the effect of LPA on cell-matrix adhesion, cells were cultured for 24 h in the presence of LPA (80 µM) before evaluation of adhesion to 24-well culture plates coated with type I collagen as previously described (29
, 30)
. Briefly, wells were coated with type I collagen or albumin (control) by passive adsorption and blocked with 3% BSA before use in adhesion assays. Control or LPA-treated cells were released by brief trypsinization (1 min, 37°C), washed in serum-containing medium to inhibit trypsin activity, and replated at a density of 1.5 x 105 cells/well. Adhesion was allowed to proceed for 1 h before washing with PBS to remove unbound cells. Bound cells were fixed and stained using Diff-Quik (Fisher) and enumerated using an ocular micrometer and counting a minimum of 10 high-powered fields. To assess integrin expression levels, control or LPA-treated cells were lysed using 50 mM Tris, 150 mM NaCl, 1% NP40, and 0.1% SDS, and protein content was determined as described above. Equal concentrations of lysate (20 µg) were electrophoresed on 9% SDS-polyacrylamide gels, electroblotted to Immobilon, and probed with an anti-ß1 integrin antibody (1:1000 dilution, 3 h) followed by a peroxidase-conjugated secondary antibody (1:5000, 1 h). After washing, immunoreactive bands were visualized using enhanced chemiluminescence detection.
Analysis of MMP-2 Expression and Activity.
Gelatinase activities in conditioned media were determined using SDS-PAGE gelatin zymography as previously described (12)
. Briefly, SDS-PAGE gels (9% acrylamide) were copolymerized with 0.1% gelatin, and samples were electrophoresed without reduction or boiling using 5x Laemmli sample buffer. SDS was removed through a 1-h incubation in 2.5% Triton X-100, and gels were incubated in 20 mM glycine, 10 mM CaCl2, 1 µM ZnCl2 (pH 8.3) at 37°C for 18–24 h before staining with Coomassie Blue to visualize zones of gelatinolytic activity. In some experiments, cultured cells were treated with LPA (80 µM) for 24 h to up-regulate integrin expression before seeding of control or LPA-treated cells into three-dimensional collagen gels as previously described (12)
. After 48 h of collagen culture, MMP-2 status was evaluated as described above. Quantitation of MMP activity was performed by monitoring hydrolysis of a quenched fluorescent peptide substrate (25)
using a fluorimetric microtiter plate reader (SpectraMAX Gemini; Molecular Devices). Aliquots of conditioned media (200 µl) from control and LPA-treated cells were incubated with 7.5 µM substrate at 37°C, and kinetics of substrate hydrolysis were monitored fluorometrically using an excitation wavelength of 326 nm and monitoring emission at 396 nm. The concentration of proMMP-2 in aliquots of conditioned medium was also quantified by ELISA according to the manufacturer’s specifications. Relative expression of TIMP-1 and -2 in conditioned media of LPA-treated cells (80 µM LPA, 24 h) were evaluated by reverse zymography. Reverse zymography for detection of TIMPs was performed using 15% SDS-polyacrylamide gels containing copolymerized gelatin using TIMP standards and reagents purchased from University Technologies International (Calgary, Alberta, Canada) according to the manufacturer’s specifications.
Evaluation of MT1-MMP Expression, Processing, and Distribution.
MT1-MMP expression and processing were evaluated by Western blotting of cell lysates as previously described (12)
. Briefly, control and LPA-treated cells were washed with PBS and lysed with 500 µl of lysis buffer (50 mM sodium phosphate buffer (pH 8.0), 150 mM NaCl, 1% NP-40, 0.5% TX-100, 1 µg/ml aprotinin, 1 µM pepstatin, 10 µM leupeptin, and 10 µM E64). Lysates were collected with a cell scraper and clarified by centrifugation (10,000 x g, 10 min, 4°C), and protein concentration was determined using the Bio-Rad Dc protein assay. Equal concentrations of protein (20 µg) were electrophoresed on 9% SDS-polyacrylamide gels, transferred to polyvinylidene difluoride membrane, and blocked with 3% BSA in 50 mM Trizma (pH 7.5), 300 mM NaCl, 0.2% Tween 20 (TBST). Membranes were incubated for 1 h at room temperature with a 1:4000 dilution of antihuman MT1-MMP polyclonal antibody in 3% BSA/TBST. Immunoreactive bands were visualized with a peroxidase-conjugated antirabbit IgG (1:5000 in 3% BSA/TBST) and enhanced chemiluminescence.
To evaluate MT1-MMP by immunofluorescence microscopy, cells were plated onto 22-mm2 glass coverslips placed into 6-well tissue culture plates and cultured in the absence or presence of LPA (80 µM) overnight. Cells were gently washed with PBS and fixed for 1 min in ice-cold methanol. Coverslips were then blocked for 45 min with PBS containing 1% BSA, followed by the addition of biotinylated anti-MT1-MMP (1:200 dilution, 1 h, room temperature). After washing three times (10 min) with PBS/1% BSA, streptavidin-FITC solution was added (1:500 dilution), and coverslips were gently agitated for 1 h at room temperature in the dark, washed as described above, and viewed using a Zeiss fluorescence microscope (Model II).
Analysis of Migration and Invasion.
A variety of approaches were used to evaluate the functional effect of LPA on motility and invasion. Chemotactic directional migration was evaluated using a modified Boyden chamber (31)
. Porous filters (8-µm pores) were coated on the underside by passive adsorption with type I collagen (Sigma) by incubating with 10 µg/ml collagen in coating buffer (29)
for 2 h. Cells (1 x 105) pretreated with LPA as described above were plated in the upper chamber in the presence or absence of LPA as indicated and allowed to migrate for 4 h. Nonmigrating cells were removed from the upper chamber with a cotton swab, filters were stained with Diff-Quik Stain, and migrating cells adherent to the underside of the filter were enumerated using an ocular micrometer and counting a minimum of 10 high-powered fields. Data are expressed as relative migration (number of cells/field) and represent the mean and SD of quadruplicate experiments. Invasive activity was quantified by plating cells (5 x 104) onto a Boyden chamber coated with Matrigel (11 µg/filter) followed by incubation for 48–72 h. Staining of filters and quantitation of invading cells was performed as described above. In some experiments, invasion was quantified in the presence of the MMPI (10 µM). Aliquots of conditioned medium were also removed and assayed for proMMP-2 activation as described above. (It should be noted that the zymogram incubation buffer did not contain MMPI, thus allowing visualization of MMP-2 species.)
Haptotactic motility was assessed as previously described (30 , 32) by plating cells (3000/coverslip) on coverslips coated with colloidal gold overlaid with type I collagen (50 µg/ml). Cells were allowed to migrate for 26 h, and phagokinetic tracks were monitored by visual examination using a Zeiss microscope with darkfield illumination. Semiquantitative analysis of phagokinetic tracks was performed by measuring track area by computer-assisted image analysis using NIHImage. Motility was also evaluated using a scratch wound assay as previously described (33) . Confluent monolayers of cells were wounded with a uniform scratch, rinsed with PBS, and incubated in the presence or absence of LPA or MMP-I for 0–24 h. Wound closure was monitored by visual examination using a Zeiss microscope. Semiquantitative analysis of wound closure was obtained by measuring the wound width on photographic images using Fowler digital needlepoint calipers accurate to 0.01 mm.
|
RESULTS |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
; P < 0.005). Concomitant with increased adhesion, expression of ß1 integrin protein was also enhanced by LPA (Fig. 1B)
. In control experiments, treatment of cells with LPA (200 µM, 72 h) did not enhance proliferation or induce toxicity (not shown). We have previously demonstrated that ß1 integrin clustering induces MT1- MMP-dependent proMMP-2 activation in ovarian cancer cells (12)
. Because the expression of ß1 integrins was up-regulated by LPA, cells were preincubated with LPA (80 µM) for 24 h before seeding into three-dimensional collagen cultures to induce integrin clustering. Preincubation with LPA enhanced the response of DOV13 cells to three-dimensional collagen culture, resulting in increased proMMP-2 processing (Fig. 1C)
.
|
, with changes observed using LPA concentrations as low as 5–10 µM. Control cultures treated with LPA 18:0 showed no changes in proMMP-2 processing (not shown). These results were confirmed by an ELISA specific for proMMP-2, demonstrating a decrease in proMMP-2 levels from 36.2 ± 0.85 ng/ml in untreated controls to 21.5 ± 1.7 and 14.3 ± 0.5 ng/ml in cells treated with 80 µM and 200 µM LPA, respectively. LPA-induced proMMP-2 activation was inhibited by coincubation with PTX (Fig. 2B)
, which was been shown to block LPA-dependent signaling via Gi protein-coupled receptors in ovarian cancer cells (2)
. Relative expression levels of the MMP inhibitors TIMP-1 and TIMP-2 were unaltered by LPA treatment, as shown by reverse zymography (Fig. 2C)
. Quantitative evaluation of MMP activity in conditioned medium using a synthetic quenched fluorescent peptide substrate confirmed the net increase in MMP-2 activity, showing a threefold increase in substrate cleavage in LPA-treated cultures (Fig. 2D)
.
|
, Lane 3), and accumulation of the Mr 55,000 active specie was captured in the presence of MMP-I (Fig. 3
, Lane 4). Although LPA-induced up-regulation of MMP-2 activation was readily apparent (Fig. 2)
, only a slight increase in the Mr 55,000 active MT1-MMP specie was detectable, as captured in LPA-treated cells in the presence of MMP-I (Fig. 3
, Lanes 5 and 6), suggesting that LPA may function via a mechanism distinct from that of integrin clustering to up-regulate cellular MMP activation. Because it has been reported that physical clustering of MT1-MMP may also potentiate proMMP-2 activation (35)
, the distribution of MT1-MMP in control and LPA-treated cells was evaluated by immunofluorescence microscopy (Fig. 3B)
. In untreated cells (Fig. 3B
, left panel) MT1-MMP expression is predominantly peri-nuclear, whereas MT1-MMP is more widely distributed at the cell surface in LPA-treated cells (right panel), suggesting an LPA-induced change in MT1-MMP trafficking or localization.
|
. Haptotactic migration, assessed using colloidal gold-coated coverslips overlaid with type I collagen (Fig. 5A)
, demonstrated that addition of LPA strongly enhanced collagen-driven motility. Quantitation of phagokinetic tracks using computer-assisted image analysis indicated an approximately threefold increase in the relative migration areas of control and LPA-treated cells, respectively (Fig. 5B)
. Additionally, LPA-stimulated motility was reduced to control levels in the presence of MMP-I (Fig. 5, A and B)
, implicating MMP activity in LPA-induced migration. Similar results were obtained in an in vitro scratch wound assay, wherein LPA-induced wound closure was significantly increased relative to control wounded cultures, and the LPA-induced increase in motility was blocked by the addition of MMP-I (Fig. 6, A and B)
. To examine the effect of LPA on in vitro invasion, cells were seeded into Boyden chambers overlaid with Matrigel to provide a three-dimensional, protein-rich barrier to migration. LPA treatment resulted in a significant increase in invasive activity (Fig. 7A)
that correlated with LPA-induced MMP-2 activation (Fig. 7B)
. Both MMP-2 processing and invasive activity were blocked by the MMP-I, providing additional evidence for the role of LPA-induced MMP activity in ovarian cancer invasion.
|
|
|
|
|
DISCUSSION |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Although the detailed mechanism by which LPA functions to promote proMMP-2 activation has not been elucidated, previous studies have demonstrated that LPA binds to ovarian cancer cells via the Edg (endothelial cell differentiation gene) receptor family (27 , 39) . Many Edg family members including Edg-2 and Edg-4 are widely expressed in ovarian cancer cells (27) and function as PTX-sensitive G protein-coupled receptors to activate multiple signal transduction pathways, including Rho GTPases (24 , 38 , 39) . We have previously described a MMP-2/MT1-MMP activation cascade in ovarian cancer cells induced by three-dimensional collagen culture via signal transduction activated by ß1 integrin clustering (12) . Our current results indicate that LPA up-regulates ß1 integrin expression, and previous studies have shown that LPA-Edg-2 receptor signaling stimulates integrin phosphorylation and formation of ß1 integrin-containing focal contacts (8) , which function synergistically with ß1 integrin signaling to promote cellular migration (8 , 34) . These data indicate that LPA-Edg binding and matrix-induced ß1 integrin clustering may function via convergent signal transduction pathways to promote MMP expression and/or processing, with subsequent downstream changes in migratory and invasive behavior. As MT1-MMP immunoreactivity is colocalized with ß1 integrins on the ovarian cancer cell surface,4 it is interesting to speculate that LPA- or matrix-induced integrin clustering may function in part to "focalize" MT1-MMP proteolytic activity to sites of cell-matrix contact, thereby promoting pericellular proteolysis and subsequent i.p. invasion.
|
ACKNOWLEDGMENTS |
|---|
|
FOOTNOTES |
|---|
1 Supported by NIH Grants RO1 CA 86984 (to M. S. S.), U01 CA 85133 (to D. A. F.), and T32 GM 08061(to S. M. E.) and the Stenn Fund for Ovarian Cancer Research. 
2 To whom requests for reprints should be addressed, at University Medical School, 303 East Chicago Avenue, Tarry 4-751, Chicago, IL 60611. Phone: (312) 908-8216; Fax: (312) 908-8773; E-mail: mss130{at}northwestern.edu
3 The abbreviations used are: LPA, lysophosphatidic acid; MMP, matrix metalloproteinase; MT-1, membrane type 1; ConA, concanavalin A; MMPI, MMP inhibitor; TIMP, tissue inhibitors of metalloproteinase; PTX, pertussis toxin.
4 S. M. Ellerbroek and M. S. Stack. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity, manuscript submitted.
Received 9/27/00. Accepted 1/26/01.
|
REFERENCES |
|---|
|
TopABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
2ß1 integrin. Int. J. Cancer, 67: 695-701, 1996.[Medline]
2ß1 integrin-mediated interaction with type I collagen. Invasion Metastasis, 18: 15-26, 1998.[Medline]
This article has been cited by other articles:
|
|
 |
|
  T. T. Li, M. Alemayehu, A. I. Aziziyeh, C. Pape, M. Pampillo, L.-M. Postovit, G. B. Mills, A. V. Babwah, and M. Bhattacharya {beta}-Arrestin/Ral Signaling Regulates Lysophosphatidic Acid-Mediated Migration and Invasion of Human Breast Tumor Cells Mol. Cancer Res., July 1, 2009; 7(7): 1064 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chen, G. Li, W. Liao, J. Wu, L. Liu, D. Ma, J. Zhou, R. H. Elbekai, M. L. Edin, D. C. Zeldin, et al. Selective Inhibitors of CYP2J2 Related to Terfenadine Exhibit Strong Activity against Human Cancers in Vitro and in Vivo J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 908 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, D. Wang, H. Zhang, K. Kirmani, Z. Zhao, R. Steinmetz, and Y. Xu Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice Mol. Cancer Ther., June 1, 2009; 8(6): 1692 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gogoi, M. Kudla, O. Gil, and D. Fishman The Activity of Medroxyprogesterone Acetate, an Androgenic Ligand, in Ovarian Cancer Cell Invasion Reproductive Sciences, October 1, 2008; 15(8): 846 - 852. [Abstract] [PDF]
|
|
|
|
|
|
N. Said, M. J. Socha, J. J. Olearczyk, A. A. Elmarakby, J. D. Imig, and K. Motamed Normalization of the Ovarian Cancer Microenvironment by SPARC Mol. Cancer Res., October 1, 2007; 5(10): 1015 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-G. Jiang, Y.-G. Ning, C. Chen, D. Ma, Z.-J. Liu, S. Yang, J. Zhou, X. Xiao, X. A. Zhang, M. L. Edin, et al. Cytochrome P450 Epoxygenase Promotes Human Cancer Metastasis Cancer Res., July 15, 2007; 67(14): 6665 - 6674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-V. Do, J. C. Symowicz, D. M. Berman, L. A. Liotta, E. F. Petricoin III, M. S. Stack, and D. A. Fishman Lysophosphatidic Acid Down-Regulates Stress Fibers and Up-Regulates Pro-Matrix Metalloproteinase-2 Activation in Ovarian Cancer Cells Mol. Cancer Res., February 1, 2007; 5(2): 121 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. Chung, O.-N. Bae, K.-M. Lim, J.-Y. Noh, M.-Y. Lee, Y.-S. Jung, and J.-H. Chung Lysophosphatidic Acid Induces Thrombogenic Activity Through Phosphatidylserine Exposure and Procoagulant Microvesicle Generation in Human Erythrocytes Arterioscler Thromb Vasc Biol, February 1, 2007; 27(2): 414 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Klemm, S. Zimmermann, C. Peschel, T. W. Mak, and J. Ruland Bcl10 and Malt1 control lysophosphatidic acid-induced NF-{kappa}B activation and cytokine production PNAS, January 2, 2007; 104(1): 134 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W.T. Cheung, P. C.K. Leung, and A. S.T. Wong Gonadotropin-Releasing Hormone Promotes Ovarian Cancer Cell Invasiveness through c-Jun NH2-Terminal Kinase-Mediated Activation of Matrix Metalloproteinase (MMP)-2 and MMP-9. Cancer Res., November 15, 2006; 66(22): 10902 - 10910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-q. Wang, Y. Smicun, N. Calluzzo, and D. A. Fishman Inhibition of Matrilysin Expression by Antisense or RNA Interference Decreases Lysophosphatidic Acid-Induced Epithelial Ovarian Cancer Invasion Mol. Cancer Res., November 1, 2006; 4(11): 831 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rosano, F. Spinella, V. Di Castro, S. Dedhar, M. R. Nicotra, P. G. Natali, and A. Bagnato Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Mol. Cancer Ther., April 1, 2006; 5(4): 833 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Wu, C.-N. Chen, C. I. Lin, J. H. Chen, and H. Lee Lysophospholipids Enhance Matrix Metalloproteinase-2 Expression in Human Endothelial Cells Endocrinology, August 1, 2005; 146(8): 3387 - 3400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, X. Ye, C. Mahanivong, D. Bian, J. Chun, and S. Huang Signaling Mechanisms Responsible for Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells J. Biol. Chem., March 18, 2005; 280(11): 10564 - 10571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Symowicz, B. P. Adley, M. M.M. Woo, N. Auersperg, L. G. Hudson, and M. S. Stack Cyclooxygenase-2 Functions as a Downstream Mediator of Lysophosphatidic Acid to Promote Aggressive Behavior in Ovarian Carcinoma Cells Cancer Res., March 15, 2005; 65(6): 2234 - 2242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Ko, S.-C. Shen, T. J.F. Lee, and Y.-C. Chen Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells Mol. Cancer Ther., February 1, 2005; 4(2): 281 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sun, J. Nishihira, T. Yoshiki, M. Kondo, Y. Sato, F. Sasaki, and S. Todo Macrophage Migration Inhibitory Factor Promotes Tumor Invasion and Metastasis via the Rho-Dependent Pathway Clin. Cancer Res., February 1, 2005; 11(3): 1050 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hashimoto, K.-i. Morishige, K. Sawada, M. Tahara, R. Kawagishi, Y. Ikebuchi, M. Sakata, K. Tasaka, and Y. Murata Alendronate Inhibits Intraperitoneal Dissemination in In vivo Ovarian Cancer Model Cancer Res., January 15, 2005; 65(2): 540 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Chou, L.-H. Wei, M.-L. Kuo, Y.-J. Huang, K.-P. Lai, C.-A. Chen, and C.-Y. Hsieh Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-{kappa}B pathway by lysophosphatidic acid, an ovarian cancer-activating factor Carcinogenesis, January 1, 2005; 26(1): 45 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Graves, E. V. Ariztia, J. R. Navari, H. J. Matzel, M. S. Stack, and D. A. Fishman Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles Cancer Res., October 1, 2004; 64(19): 7045 - 7049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bian, S. Su, C. Mahanivong, R. K. Cheng, Q. Han, Z. K. Pan, P. Sun, and S. Huang Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway Cancer Res., June 15, 2004; 64(12): 4209 - 4217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Fang, S. Yu, R. C. Bast, S. Liu, H.-J. Xu, S.-X. Hu, R. LaPushin, F. X. Claret, B. B. Aggarwal, Y. Lu, et al. Mechanisms for Lysophosphatidic Acid-induced Cytokine Production in Ovarian Cancer Cells J. Biol. Chem., March 5, 2004; 279(10): 9653 - 9661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamada, K. Sato, M. Komachi, E. Malchinkhuu, M. Tobo, T. Kimura, A. Kuwabara, Y. Yanagita, T. Ikeya, Y. Tanahashi, et al. Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA1 J. Biol. Chem., February 20, 2004; 279(8): 6595 - 6605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, R. Cummings, Y. Zhao, A. Kazlauskas, J. K. S. Sham, A. Morris, S. Georas, D. N. Brindley, and V. Natarajan Involvement of Phospholipase D2 in Lysophosphatidate-induced Transactivation of Platelet-derived Growth Factor Receptor-{beta} in Human Bronchial Epithelial Cells J. Biol. Chem., October 10, 2003; 278(41): 39931 - 39940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stahle, C. Veit, U. Bachfischer, K. Schierling, B. Skripczynski, A. Hall, P. Gierschik, and K. Giehl Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK J. Cell Sci., September 15, 2003; 116(18): 3835 - 3846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Shida, J. Kitayama, H. Yamaguchi, Y. Okaji, N. H. Tsuno, T. Watanabe, Y. Takuwa, and H. Nagawa Lysophosphatidic Acid (LPA) Enhances the Metastatic Potential of Human Colon Carcinoma DLD1 Cells through LPA1 Cancer Res., April 1, 2003; 63(7): 1706 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sawada, K.-i. Morishige, M. Tahara, R. Kawagishi, Y. Ikebuchi, K. Tasaka, and Y. Murata Alendronate Inhibits Lysophosphatidic Acid-induced Migration of Human Ovarian Cancer Cells by Attenuating the Activation of Rho Cancer Res., November 1, 2002; 62(21): 6015 - 6020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gschwind, N. Prenzel, and A. Ullrich Lysophosphatidic Acid-induced Squamous Cell Carcinoma Cell Proliferation and Motility Involves Epidermal Growth Factor Receptor Signal Transactivation Cancer Res., November 1, 2002; 62(21): 6329 - 6336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Tam, Y. I. Wu, G. S. Butler, M. S. Stack, and C. M. Overall Collagen Binding Properties of the Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Hemopexin C Domain. THE ECTODOMAIN OF THE 44-kDa AUTOCATALYTIC PRODUCT OF MT1-MMP INHIBITS CELL INVASION BY DISRUPTING NATIVE TYPE I COLLAGEN CLEAVAGE J. Biol. Chem., October 4, 2002; 277(41): 39005 - 39014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rosano, M. Varmi, D. Salani, V. Di Castro, F. Spinella, P. Giorgio Natali, and A. Bagnato Endothelin-1 Induces Tumor Proteinase Activation and Invasiveness of Ovarian Carcinoma Cells Cancer Res., November 1, 2001; 61(22): 8340 - 8346. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
, 80 µM) or absence (
) of LPA and analyzed for adhesion to wells coated by passive adsorption with type I collagen. Cells (1.5 x 105) were added to wells for 1 h at 37°C. After washing to remove nonadherent cells, bound cells were fixed and enumerated using an ocular micrometer by counting 10 high-power fields. Data represent the mean and SD from triplicate experiments (**, P < 0.005 relative to control). B, LPA induces expression of ß1 integrin. Cells were cultured in the absence (Lane 1) or presence (Lane 2) of LPA as described above. Cells were lysed and lysates (20 µg) were electrophoresed on 9% SDS-polyacrylamide gels and immunoblotted with anti-ß1 integrin, followed by peroxidase-conjugated secondary antibody and enhanced chemiluminescence detection. C, LPA enhances collagen-induced proMMP-2 processing. Cells were cultured for 24 h in the absence or presence of LPA (80 µM) before subculturing onto three-dimensional collagen gels 
